Even though the reasons why the laboratories were unable to test for these diseases were not investigated in the current study, this finding suggests that the demand for diagnostic testing of these diseases (FMD, RVF, brucellosis, and tick-borne diseases) may be high, but provision is inadequate. The gene discussed is FLNA; the disease is brucellosis.